December 7, 2021
Towa Pharmaceutical said on December 3 that it has gained approval for partial changes to its version of Chugai Pharmaceutical’s osteoporosis agent Edirol (eldecalcitol), making the product an authorized generic (AG) version. This is the first case of an AG...read more